Medical Second Opinion Market to Reach USD 34.57 Billion by 2035

Industry

โดย GlobeNewswire·Read original

Summary · why it matters

The global medical second opinion market is projected to grow from USD 8.36 billion in 2025 to USD 34.57 billion by 2035, at a compound annual growth rate of 15.3 percent, according to a new report by SNS Insider. The hospital physicians and specialties segment led the market in 2025 with a 41.6 percent share, while the in-house source of service segment held a 57.8 percent revenue share. Cancer applications accounted for 38.4 percent of the market, driven by the complexity of oncological diagnosis and treatment. North America dominated the global market in 2025, with the U.S. market alone valued at approximately USD 3.44 billion and expected to reach USD 14.22 billion by 2035. Key players include Teladoc Health, Included Health, Cleveland Clinic, Mayo Clinic, and Johns Hopkins Medicine International.

Teladoc Inc ▲

Impact on stocks 1

Health Care▲ · 1 stocks

▲ PositiveDemandrelevance

Teladoc Health is listed as a key player in the growing medical second opinion market, which is projected to expand significantly.

Off-coverage companies 2

Included HealthPrivate▲ Positive

Demandrelevance

Included Health is listed as a key player in the growing medical second opinion market, which is projected to expand significantly.

Cleveland ClinicPrivate▲ Positive

Demandrelevance

Cleveland Clinic is listed as a key player in the growing medical second opinion market, which is projected to expand significantly.